Semiquantitative Approach to Amyloid Positron Emission Tomography Interpretation in Clinical Practice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Semiquantitative Approach to Amyloid Positron Emission Tomography Interpretation in Clinical Practice ; day:28 ; month:10 ; year:2022
World Journal of Nuclear Medicine ; (28.10.2022)
- Beteiligte Personen und Organisationen
-
Franceschi, Ana M.
Petrover, David R.
Giliberto, Luca
Clouston, Sean A. P.
Gordon, Marc L.
- DOI
-
10.1055/s-0042-1757290
- URN
-
urn:nbn:de:101:1-2022122210165952410596
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Franceschi, Ana M.
- Petrover, David R.
- Giliberto, Luca
- Clouston, Sean A. P.
- Gordon, Marc L.
Ähnliche Objekte (12)
Positron emission tomography
Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
Visual versus semiquantitative analysis of 18F-fluorodeoxyglucose-positron emission tomography brain images in patients with dementia
Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
Positron emission tomography imaging of amyloid-beta plaque deposition: a decade of translation
Positron emission tomography of the brain
Positron emission tomography in experimental perinatology
Positron Emission Tomography Imaging in Sarcoidosis
Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab
Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review
Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer’s Disease
Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity
Positron emission tomography
Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
Visual versus semiquantitative analysis of 18F-fluorodeoxyglucose-positron emission tomography brain images in patients with dementia
Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
Positron emission tomography imaging of amyloid-beta plaque deposition: a decade of translation
Positron emission tomography of the brain
Positron emission tomography in experimental perinatology
Positron Emission Tomography Imaging in Sarcoidosis
Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab
Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review
Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer’s Disease
Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity
Positron emission tomography
Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
Visual versus semiquantitative analysis of 18F-fluorodeoxyglucose-positron emission tomography brain images in patients with dementia
Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
Positron emission tomography imaging of amyloid-beta plaque deposition: a decade of translation
Positron emission tomography of the brain
Positron emission tomography in experimental perinatology
Positron Emission Tomography Imaging in Sarcoidosis
Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab
Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review
Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer’s Disease